A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults

NCT01462851 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-05297909 25 mg
DRUG: PF-05297909 100 mg
DRUG: PF-05297909 250 mg
DRUG: PF-05297909 525 mg
DRUG: PF-05297909 525 mg

Sponsor

Pfizer